400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR2500110717
尚未开始
/
/
/
2025-10-20
/
/
Colorectal Cancer
WhatsApp-assisted prehabilitation programme for adult patient undergoing elective colorectal cancer surgery
WhatsApp-assisted prehabilitation programme for adult patient undergoing elective colorectal cancer surgery
1.To develop and implement a technology-assisted prehabilitation for CRC patient undergoing elective surgery. 2.To examine the effects of the technology-assisted prehabilitation on postoperative complications, length of stay (LOS), physical activity (PA), nutritional status, gastrointestinal (GI) recovery and psychological well-being. 3.To evaluate the feasibility and patients' perception towards the technology-assisted prehabilitation.
随机平行对照
其它
A computer-based randomization will be utilized to allocate patients into either one group. Eligible participants will be randomly assigned in a 1:1 ratio to either control group or intervention group. Block randomization was performed through a computer-generated sequence, and serial and opaque with sealed envelopes will be prepared in by independent staff not involved in clinical care or screening or assessment, in which will be used to conceal the sequence until the intervention as assigned at the outpatient preoperative clinic
Assessor will be blinded for the allocation of the participants and intervention.
None
/
50
/
2025-09-10
2026-12-31
/
Patients (1) aged over 18, (2) scheduled for elective colorectal cancer surgery as primary treatment, (3) possess a smart technology with internet plan or WIFI access, (4) able to use WhatsApp application with read, write and interact, (5) can understand Chinese (Cantonese) and follow instructions.;
请登录查看Patients with (1) expected surgery date less than 21 days, (2) identified cognitive disorder, (3) respiratory disease or (4) musculoskeletal problems, that is, showed difficulties in understanding the study procedures, providing informed consent or following instructions, in their medical records, (5) requiring neoadjuvant therapy. Participants will be also excluded if their surgery is cancelled (as judged by surgeon or patient refused operation) after randomization.;
请登录查看The Chinese University of Hong Kong
/
GSK中国2026-01-30
上海市浦东新区生物产业行业协会2026-01-30
罕见病信息网2026-01-30
中肽生化2026-01-30
Farsightpharma睿诺医疗科技2026-01-30
丁香园 Insight 数据库2026-01-30
一度医药2026-01-30
晨泰医药2026-01-30
医麦创新药2026-01-30
医药观澜2026-01-30